NasdaqGS - Nasdaq Real Time Price USD

Bioceres Crop Solutions Corp. (BIOX)

Compare
10.64 -0.43 (-3.88%)
At close: August 30 at 4:00 PM EDT
10.64 0.00 (0.00%)
After hours: August 30 at 4:00 PM EDT
Loading Chart for BIOX
DELL
  • Previous Close 11.07
  • Open 11.10
  • Bid --
  • Ask --
  • Day's Range 10.64 - 11.11
  • 52 Week Range 9.71 - 14.05
  • Volume 91,095
  • Avg. Volume 60,864
  • Market Cap (intraday) 644.649M
  • Beta (5Y Monthly) 0.46
  • PE Ratio (TTM) 266.00
  • EPS (TTM) 0.04
  • Earnings Date Sep 9, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 18.60

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops. The Crop Protection segment develops, produces, and markets Rizoderma, adjuvants, therapies, herbicides, insecticides, fungicides, and baits. The Crop Nutrition segment develops, produces, commercializes, and sells inoculants, bio-inductors, and biological and microgranulated fertilizers. It also offers HB4, a drought tolerant seed technology program. The company operates in Argentina, Bolivia, Brazil, Colombia, Estonia, the United States, Paraguay, Russia, South Africa, France, Uruguay, and internationally. Bioceres Crop Solutions Corp. was founded in 2001 and is headquartered in Rosario, Argentina.

biocerescrops.com

--

Full Time Employees

June 30

Fiscal Year Ends

Recent News: BIOX

View More

Performance Overview: BIOX

Trailing total returns as of 8/30/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

BIOX
22.51%
S&P 500
18.42%

1-Year Return

BIOX
8.51%
S&P 500
25.59%

3-Year Return

BIOX
22.34%
S&P 500
25.26%

5-Year Return

BIOX
86.99%
S&P 500
93.14%

Compare To: BIOX

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: BIOX

View More

Valuation Measures

Annual
As of 8/30/2024
  • Market Cap

    644.65M

  • Enterprise Value

    866.91M

  • Trailing P/E

    242.37

  • Forward P/E

    12.67

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.57

  • Price/Book (mrq)

    2.06

  • Enterprise Value/Revenue

    1.95

  • Enterprise Value/EBITDA

    16.35

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.69%

  • Return on Assets (ttm)

    2.68%

  • Return on Equity (ttm)

    1.62%

  • Revenue (ttm)

    445.59M

  • Net Income Avi to Common (ttm)

    3.07M

  • Diluted EPS (ttm)

    0.04

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    32.81M

  • Total Debt/Equity (mrq)

    73.19%

  • Levered Free Cash Flow (ttm)

    -12M

Research Analysis: BIOX

View More

Company Insights: BIOX

Research Reports: BIOX

View More

People Also Watch